Search

Author/Creator Paturel, Carine

1. IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. Issue 8 (August 2019)

Authors:
Bagot, Martine; Porcu, Pierluigi; Marie-Cardine, Anne; Battistella, Maxime; William, Basem M; Vermeer, Maarten; Whittaker, Sean; Rotolo, Federico; Ram-Wolff, Caroline; Khodadoust, Michael S; Bensussan, Armand; Paturel, Carine; Bonnafous, Cecile; Sicard, Helene; Azim, Hatem A; Kim, Youn H
Journal:
Lancet oncology
Issue:
Volume 20:Issue 8(2019)
Page Start:
1160
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas. (7th November 2013)

Authors:
Marie-Cardine, Anne; Viaud, Nicolas; Dujardin, Arnaud; Rachel, Joly; Granier, Nathalie; Gauthier, Laurent; Bonnafous, Cecile; Blery, Mathieu; Paturel, Carine; Bensussan, Armand; Bagot, Martine; Sicard, Helene
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting MICA with therapeutic antibodies for the treatment of cancer. (7th November 2013)

Authors:
Bonnafous, Cécile; Peri, Valentine; Trichard, Sylvia; Perrot, Ivan; Cornen, Stéphanie; Thielens, Ariane; Breso, Violette; Morel, Yannis; Rossi, Benjamin; Paturel, Carine; Gauthier, Laurent; Bléry, Mathieu
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search